Cesare Orlandi
Director/Miembro de la Junta en American Heart Association, Inc. .
Perfil
Cesare Orlandi is currently the Director at the American Heart Association, Inc. and a Member at the American Society of Nuclear Cardiology.
He previously held positions such as Assistant Director-Clinical Development at DuPont Merck Pharmaceutical Co., Vice President-Research & Development at King Pharmaceuticals Research & Development, Inc., and Principal at The Upjohn Co. From 1998 to 2007, he was the Vice President-Global Clinical Development at Otsuka Pharmaceutical Co., Ltd.
He also served as the Chief Medical Officer & Senior Vice President at VTVX Holdings I LLC, CardioKine, Inc., and Lantheus Medical Imaging, Inc. from 2012 to 2013, 2007 to 2011, and 2013 to 2019, respectively.
Dr. Orlandi holds a doctorate degree from the University of Pavia Medical School.
Cargos activos de Cesare Orlandi
| Empresas | Cargo | Inicio |
|---|---|---|
| American Society of Nuclear Cardiology | Corporate Officer/Principal | - |
American Heart Association, Inc.
 American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Cesare Orlandi.
| Empresas | Cargo | Fin |
|---|---|---|
| LANTHEUS HOLDINGS, INC. | Director Técnico/Científico/I+D | 02/09/2019 |
Lantheus Medical Imaging, Inc.
 Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Director Técnico/Científico/I+D | 01/09/2019 |
VTVX Holdings I LLC
 VTVX Holdings I LLC Miscellaneous Commercial ServicesCommercial Services VTVX Holdings I LLC discovers, develops and commercializes human therapeutics to fill unmet medical needs. Its products include a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a range of human diseases, including central nervous system disorders, cardiovascular disorders, type I/II diabetes, obesity, metabolic diseases, inflammatory diseases, female sexual dysfunction, primary open angle glaucoma and cancer. The company was founded in 1998 by Dr. Adnan M. M. Mjalli and is headquartered in High Point, NC. | Director Técnico/Científico/I+D | - |
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Director Técnico/Científico/I+D | 01/01/2011 |
Otsuka Pharmaceutical Co., Ltd.
 Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Otsuka Pharmaceutical Co. Ltd. engages in the manufacturing, distributing, exporting, and importing of pharmaceuticals, clinical testing equipment, medical device and equipment, food products, cosmetics, and other related products. Its operations are carried out through the following business divisions: Pharmaceutical Business and Nutraceutical Business. The Pharmaceutical Business division engages in the manufacture and sale of pharmaceutical products for the diagnosis and treatment of diseases. The Nutraceutical Business division provides nutritional products, cosmetics and medicines that support day-to-day health maintenance and improvement. The company was founded on August 10, 1964 and is headquartered in Tokyo, Japan. | Corporate Officer/Principal | 01/01/2007 |
Formación de Cesare Orlandi.
| University of Pavia Medical School | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| LANTHEUS HOLDINGS, INC. | Health Technology |
| Empresas privadas | 9 |
|---|---|
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Health Technology |
VTVX Holdings I LLC
VTVX Holdings I LLC Miscellaneous Commercial ServicesCommercial Services VTVX Holdings I LLC discovers, develops and commercializes human therapeutics to fill unmet medical needs. Its products include a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a range of human diseases, including central nervous system disorders, cardiovascular disorders, type I/II diabetes, obesity, metabolic diseases, inflammatory diseases, female sexual dysfunction, primary open angle glaucoma and cancer. The company was founded in 1998 by Dr. Adnan M. M. Mjalli and is headquartered in High Point, NC. | Commercial Services |
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Otsuka Pharmaceutical Co. Ltd. engages in the manufacturing, distributing, exporting, and importing of pharmaceuticals, clinical testing equipment, medical device and equipment, food products, cosmetics, and other related products. Its operations are carried out through the following business divisions: Pharmaceutical Business and Nutraceutical Business. The Pharmaceutical Business division engages in the manufacture and sale of pharmaceutical products for the diagnosis and treatment of diseases. The Nutraceutical Business division provides nutritional products, cosmetics and medicines that support day-to-day health maintenance and improvement. The company was founded on August 10, 1964 and is headquartered in Tokyo, Japan. | Health Technology |
| King Pharmaceuticals Research & Development, Inc. | Health Technology |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
| American Society of Nuclear Cardiology | |
| The Upjohn Co. | Health Technology |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Commercial Services |
- Bolsa de valores
- Insiders
- Cesare Orlandi